Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Naresh Mandava

Concepts (373)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
21
2023
157
4.910
 Why?
Geographic Atrophy
10
2025
69
3.260
 Why?
Visual Acuity
20
2024
322
2.260
 Why?
Retinal Detachment
6
2023
56
2.080
 Why?
Wet Macular Degeneration
7
2025
46
2.020
 Why?
Fluorescein Angiography
18
2025
143
1.980
 Why?
Diabetic Retinopathy
11
2023
171
1.900
 Why?
Retinal Drusen
4
2024
31
1.820
 Why?
Tomography, Optical Coherence
13
2025
187
1.770
 Why?
Angiogenesis Inhibitors
17
2023
215
1.750
 Why?
Registries
8
2025
1877
1.650
 Why?
Vitreous Body
16
2022
105
1.180
 Why?
Vitrectomy
12
2020
63
1.100
 Why?
Multimodal Imaging
2
2025
109
1.060
 Why?
Macula Lutea
2
2023
21
1.030
 Why?
Retina
10
2021
282
0.900
 Why?
Vascular Endothelial Growth Factor A
12
2023
500
0.840
 Why?
Retinal Diseases
4
2023
86
0.830
 Why?
Antibodies, Monoclonal
9
2011
1355
0.820
 Why?
Retinal Neovascularization
2
2019
22
0.760
 Why?
Choroidal Neovascularization
6
2019
52
0.740
 Why?
National Eye Institute (U.S.)
1
2020
6
0.720
 Why?
Retinal Perforations
4
2015
14
0.700
 Why?
Quarantine
1
2020
27
0.690
 Why?
Biomarkers
7
2025
3880
0.680
 Why?
Aged, 80 and over
18
2025
7033
0.660
 Why?
Choroid
6
2024
61
0.630
 Why?
Retinopathy of Prematurity
4
2024
138
0.610
 Why?
Estrogen Replacement Therapy
1
2019
137
0.610
 Why?
Retinitis Pigmentosa
3
2021
20
0.590
 Why?
Aged
30
2025
21953
0.580
 Why?
Follow-Up Studies
15
2025
4892
0.550
 Why?
Intraocular Pressure
6
2012
295
0.530
 Why?
Epiretinal Membrane
3
2010
7
0.530
 Why?
Automobile Driving
1
2018
141
0.530
 Why?
Scleral Buckling
3
2019
18
0.490
 Why?
Proliferating Cell Nuclear Antigen
2
2007
50
0.490
 Why?
Vitreoretinopathy, Proliferative
2
2007
12
0.490
 Why?
Humans
80
2025
128417
0.480
 Why?
Female
50
2025
68153
0.460
 Why?
Optic Neuropathy, Ischemic
3
2013
30
0.450
 Why?
RNA, Catalytic
2
2007
185
0.450
 Why?
Self Report
1
2018
801
0.450
 Why?
Antibodies, Monoclonal, Humanized
11
2015
755
0.450
 Why?
Male
48
2025
62857
0.440
 Why?
Recombinant Fusion Proteins
4
2013
634
0.430
 Why?
Prospective Studies
9
2025
7036
0.430
 Why?
Middle Aged
31
2025
30889
0.410
 Why?
Research Design
1
2019
1036
0.410
 Why?
Surveys and Questionnaires
4
2022
5362
0.400
 Why?
Bevacizumab
11
2015
129
0.400
 Why?
Fundus Oculi
5
2025
61
0.400
 Why?
Retinal Necrosis Syndrome, Acute
2
2013
7
0.390
 Why?
Pandemics
1
2020
1476
0.380
 Why?
Retinal Vein Occlusion
2
2015
13
0.380
 Why?
Photography
4
2015
97
0.380
 Why?
Endophthalmitis
3
2017
28
0.370
 Why?
Uveal Diseases
2
2013
5
0.370
 Why?
Colorado
8
2025
4375
0.360
 Why?
Cataract
2
2020
194
0.360
 Why?
Diagnostic Techniques, Ophthalmological
2
2015
38
0.350
 Why?
Complement Factor B
2
2022
105
0.330
 Why?
Visual Fields
3
2022
87
0.330
 Why?
Glycogen Storage Disease Type IIb
2
2007
25
0.330
 Why?
Retrospective Studies
24
2024
14454
0.320
 Why?
Vision, Low
4
2022
16
0.320
 Why?
Pigment Epithelium of Eye
2
2006
34
0.320
 Why?
Retinal Pigment Epithelium
2
2024
69
0.320
 Why?
Injections
6
2010
172
0.310
 Why?
Complement Activation
3
2022
365
0.310
 Why?
Ophthalmology
2
2013
82
0.310
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1275
0.300
 Why?
Ocular Hypertension
1
2009
64
0.300
 Why?
Phacoemulsification
3
2020
115
0.280
 Why?
Optic Nerve Injuries
1
2007
5
0.280
 Why?
Macular Edema
2
2015
41
0.280
 Why?
Encephalitis, Herpes Simplex
1
2007
21
0.280
 Why?
Quantum Dots
2
2021
36
0.280
 Why?
Vision Disorders
2
2022
136
0.280
 Why?
von Hippel-Lindau Disease
1
2007
12
0.270
 Why?
Papilledema
1
2007
39
0.270
 Why?
Fovea Centralis
2
2010
11
0.270
 Why?
Puerperal Disorders
1
2007
30
0.270
 Why?
Glucocorticoids
2
2013
571
0.270
 Why?
Triamcinolone Acetonide
1
2006
27
0.260
 Why?
Ocular Hypotension
1
2006
10
0.260
 Why?
Herpesvirus 1, Human
1
2007
85
0.260
 Why?
Ciliary Body
1
2006
33
0.250
 Why?
Myopia
1
2006
47
0.250
 Why?
Telangiectasis
1
2005
6
0.250
 Why?
Granuloma
1
2006
84
0.250
 Why?
Chemokine CCL5
2
2023
42
0.240
 Why?
DNA, Viral
1
2007
348
0.240
 Why?
Retinal Vessels
1
2005
64
0.240
 Why?
Retinal Ganglion Cells
4
2022
97
0.240
 Why?
Diabetes Mellitus
2
2023
999
0.220
 Why?
Laser Therapy
2
2021
130
0.220
 Why?
Disease Progression
5
2025
2602
0.220
 Why?
Fluorocarbons
1
2005
109
0.220
 Why?
Vision Tests
1
2023
16
0.220
 Why?
Birth Weight
2
2024
498
0.220
 Why?
Diseases in Twins
1
2024
176
0.220
 Why?
Temporal Arteries
2
2015
45
0.220
 Why?
Risk Factors
10
2024
9704
0.210
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2013
89
0.210
 Why?
Twins
1
2024
249
0.210
 Why?
Hemianopsia
1
2022
9
0.200
 Why?
Cross-Sectional Studies
5
2024
5039
0.200
 Why?
Disease Models, Animal
4
2012
3937
0.200
 Why?
Optic Disk
3
2010
40
0.190
 Why?
Ophthalmoscopy
2
2015
35
0.190
 Why?
Posterior Capsulotomy
1
2021
7
0.190
 Why?
Posterior Capsule of the Lens
1
2021
11
0.190
 Why?
Capsule Opacification
1
2021
21
0.180
 Why?
Lasers, Solid-State
1
2021
22
0.180
 Why?
Complement System Proteins
2
2022
307
0.180
 Why?
Ranibizumab
5
2013
20
0.180
 Why?
Sickness Impact Profile
1
2020
55
0.180
 Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.180
 Why?
Neurodegenerative Diseases
1
2022
110
0.170
 Why?
Herpesvirus 3, Human
2
2015
330
0.170
 Why?
Nerve Fibers
2
2010
87
0.170
 Why?
Electrodes, Implanted
2
2018
105
0.170
 Why?
Intravitreal Injections
6
2020
54
0.170
 Why?
Protective Factors
1
2019
91
0.160
 Why?
Odds Ratio
2
2019
1023
0.160
 Why?
Ischemia
2
2017
395
0.160
 Why?
Intraoperative Complications
1
2020
130
0.160
 Why?
Complement Membrane Attack Complex
1
2019
33
0.160
 Why?
Complement C3a
1
2019
40
0.160
 Why?
C-Reactive Protein
1
2021
397
0.160
 Why?
Visual Prosthesis
1
2018
1
0.150
 Why?
Cohort Studies
5
2020
5388
0.150
 Why?
Postoperative Complications
3
2021
2485
0.140
 Why?
Quality of Life
4
2022
2680
0.140
 Why?
Orbit
2
2010
57
0.140
 Why?
Metformin
1
2021
312
0.140
 Why?
Anterior Eye Segment
1
2017
9
0.140
 Why?
Reproducibility of Results
2
2023
3020
0.140
 Why?
Gestational Age
4
2024
867
0.140
 Why?
Fetal Membranes, Premature Rupture
1
2017
35
0.140
 Why?
Labor, Induced
1
2017
30
0.140
 Why?
Strabismus
1
2017
28
0.140
 Why?
Laser Coagulation
3
2012
57
0.140
 Why?
Labor, Obstetric
1
2017
58
0.130
 Why?
Time Factors
4
2021
6482
0.130
 Why?
Giant Cell Arteritis
2
2015
47
0.130
 Why?
Ophthalmologic Surgical Procedures
1
2017
56
0.130
 Why?
Immunosuppressive Agents
2
2013
680
0.130
 Why?
Retinal Degeneration
2
2015
37
0.130
 Why?
Blindness
3
2013
37
0.130
 Why?
Recovery of Function
1
2019
641
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.120
 Why?
Phenotype
3
2022
3044
0.120
 Why?
Case-Control Studies
2
2020
3328
0.120
 Why?
Incidence
2
2020
2616
0.120
 Why?
Vitreoretinal Surgery
1
2015
3
0.120
 Why?
Eye Infections, Bacterial
1
2015
27
0.120
 Why?
Multivariate Analysis
1
2019
1484
0.120
 Why?
Needles
1
2015
56
0.120
 Why?
Vitreous Detachment
1
2015
10
0.120
 Why?
Encephalitis, Varicella Zoster
1
2015
17
0.120
 Why?
Biopsy, Needle
1
2015
188
0.120
 Why?
Treatment Outcome
7
2021
10151
0.120
 Why?
Oculomotor Muscles
1
2014
37
0.120
 Why?
Antiviral Agents
2
2013
703
0.120
 Why?
Wounds, Gunshot
2
2010
213
0.120
 Why?
Inflammation
3
2023
2654
0.120
 Why?
Proteins
1
2020
932
0.110
 Why?
Rats, Inbred BN
3
2011
53
0.110
 Why?
Logistic Models
1
2019
1974
0.110
 Why?
Anti-Inflammatory Agents
2
2021
468
0.110
 Why?
Proteomics
1
2020
1009
0.110
 Why?
Fibrin
1
2014
68
0.110
 Why?
Exchange Transfusion, Whole Blood
1
2013
14
0.110
 Why?
Uvea
1
2013
1
0.110
 Why?
Drug Packaging
2
2011
40
0.110
 Why?
Uveomeningoencephalitic Syndrome
1
2013
7
0.110
 Why?
Retinal Artery Occlusion
1
2013
8
0.110
 Why?
Drug Resistance, Multiple, Viral
1
2013
11
0.110
 Why?
Tendons
1
2014
126
0.110
 Why?
Premature Birth
1
2017
310
0.110
 Why?
Cytomegalovirus Retinitis
1
2013
18
0.110
 Why?
Adult
15
2020
35299
0.100
 Why?
Isoxazoles
1
2013
54
0.100
 Why?
Lymphoproliferative Disorders
1
2013
54
0.100
 Why?
Silicon
1
2012
14
0.100
 Why?
Fatty Acids, Omega-3
1
2014
137
0.100
 Why?
Lens Subluxation
1
2012
3
0.100
 Why?
Viremia
1
2013
130
0.100
 Why?
Trabecular Meshwork
1
2013
79
0.100
 Why?
Exanthema
1
2013
73
0.100
 Why?
Uveitis, Posterior
1
2012
12
0.100
 Why?
Diagnostic Imaging
1
2015
330
0.100
 Why?
Electric Stimulation Therapy
1
2012
60
0.100
 Why?
Fluocinolone Acetonide
1
2012
19
0.100
 Why?
Diagnosis, Differential
4
2013
1416
0.100
 Why?
Microsurgery
1
2012
70
0.090
 Why?
Placenta
1
2018
716
0.090
 Why?
Particulate Matter
2
2011
245
0.090
 Why?
Vascular Endothelial Growth Factors
1
2011
65
0.090
 Why?
Fluorescein-5-isothiocyanate
2
2009
36
0.090
 Why?
Global Health
1
2014
327
0.090
 Why?
Electroretinography
2
2012
45
0.090
 Why?
Silicone Oils
1
2011
26
0.090
 Why?
Health Care Costs
1
2014
367
0.090
 Why?
Drug Storage
1
2011
52
0.090
 Why?
Glaucoma
2
2010
216
0.090
 Why?
Dextrans
2
2009
82
0.090
 Why?
Dissection
1
2011
52
0.090
 Why?
Antioxidants
1
2014
538
0.090
 Why?
Infliximab
2
2007
100
0.080
 Why?
Lysosomal-Associated Membrane Protein 2
2
2007
28
0.080
 Why?
Protein Multimerization
1
2011
178
0.080
 Why?
Anemia, Sickle Cell
1
2013
252
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
413
0.080
 Why?
Clinical Trials, Phase II as Topic
1
2009
71
0.080
 Why?
Clinical Trials, Phase I as Topic
1
2009
50
0.080
 Why?
United States
3
2020
13830
0.080
 Why?
Tonometry, Ocular
1
2009
88
0.080
 Why?
Herpes Zoster
1
2013
317
0.080
 Why?
Bacteria
1
2015
808
0.080
 Why?
Rats
4
2012
5165
0.080
 Why?
Scotoma
1
2008
5
0.070
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
250
0.070
 Why?
Retinal Artery
1
2007
16
0.070
 Why?
RNA, Messenger
2
2007
2675
0.070
 Why?
Vitreous Hemorrhage
1
2007
5
0.070
 Why?
Cerebral Angiography
1
2007
109
0.070
 Why?
Acyclovir
1
2007
93
0.070
 Why?
Dose-Response Relationship, Drug
2
2009
1936
0.070
 Why?
Frameshift Mutation
1
2006
31
0.070
 Why?
Ultrasonography
2
2007
710
0.060
 Why?
Secondary Prevention
1
2007
219
0.060
 Why?
Animals
7
2014
34479
0.060
 Why?
Conjunctival Neoplasms
1
2005
7
0.060
 Why?
Indocyanine Green
1
2005
19
0.060
 Why?
Internationality
2
2018
148
0.060
 Why?
Eye Injuries, Penetrating
1
2005
16
0.060
 Why?
Coloring Agents
1
2005
76
0.060
 Why?
Eye Foreign Bodies
1
2005
23
0.060
 Why?
Infant, Newborn
3
2024
5687
0.060
 Why?
beta-Thalassemia
1
2006
37
0.060
 Why?
Eye Injuries
1
2006
45
0.060
 Why?
Staining and Labeling
1
2005
137
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2007
1185
0.060
 Why?
Uveitis
1
2006
127
0.060
 Why?
Antihypertensive Agents
1
2009
485
0.060
 Why?
Metals
1
2005
127
0.060
 Why?
Mydriatics
1
2004
3
0.060
 Why?
Pregnancy
3
2018
6357
0.060
 Why?
Pupil
1
2004
13
0.060
 Why?
Polymerase Chain Reaction
1
2007
1020
0.060
 Why?
Sclera
2
2014
36
0.060
 Why?
Hospitals, County
1
2023
10
0.050
 Why?
Sensitivity and Specificity
2
2008
1815
0.050
 Why?
Fibroblasts
2
2013
935
0.050
 Why?
Observer Variation
1
2004
312
0.050
 Why?
Cardiomyopathy, Dilated
1
2007
377
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
2
2019
815
0.050
 Why?
Young Adult
6
2019
12312
0.050
 Why?
Double-Blind Method
1
2007
1848
0.050
 Why?
Chimera
1
2002
59
0.050
 Why?
Enzyme Stability
1
2002
67
0.050
 Why?
Autoimmune Diseases
1
2006
423
0.050
 Why?
Interleukin-4
1
2023
212
0.050
 Why?
Complement Factor I
1
2022
12
0.050
 Why?
Endopeptidases
1
2002
83
0.050
 Why?
Preventive Medicine
1
2002
41
0.050
 Why?
Aqueous Humor
1
2022
33
0.050
 Why?
Blood
1
2002
99
0.050
 Why?
Coculture Techniques
1
2002
226
0.050
 Why?
Albumins
1
2022
101
0.050
 Why?
Retreatment
2
2012
69
0.050
 Why?
Fibrinogen
1
2022
158
0.050
 Why?
Rabbits
1
2002
758
0.050
 Why?
Cells, Cultured
2
2013
4001
0.040
 Why?
Lenses, Intraocular
1
2021
43
0.040
 Why?
Cell Division
1
2002
778
0.040
 Why?
Drug Compounding
2
2011
94
0.040
 Why?
Equipment Design
2
2014
518
0.040
 Why?
Electric Stimulation
1
2021
267
0.040
 Why?
Immunologic Factors
1
2022
225
0.040
 Why?
Chronic Disease
1
2006
1705
0.040
 Why?
Cell Survival
2
2013
1077
0.040
 Why?
Lipids
1
2002
620
0.040
 Why?
Postoperative Period
1
2019
324
0.040
 Why?
Melanoma
1
2005
752
0.040
 Why?
Immunity, Maternally-Acquired
1
2018
18
0.040
 Why?
Infant
3
2020
8914
0.040
 Why?
Prevalence
2
2015
2547
0.040
 Why?
Combined Modality Therapy
2
2013
1204
0.040
 Why?
Primary Health Care
1
2008
1668
0.040
 Why?
Longitudinal Studies
1
2025
2710
0.040
 Why?
Iris Diseases
1
2017
6
0.040
 Why?
Choroid Diseases
1
2017
10
0.030
 Why?
Referral and Consultation
1
2022
727
0.030
 Why?
Prosthesis Implantation
1
2018
144
0.030
 Why?
Parity
1
2017
120
0.030
 Why?
Sex Characteristics
1
2022
721
0.030
 Why?
Infant, Low Birth Weight
1
2017
135
0.030
 Why?
Mental Health
1
2022
686
0.030
 Why?
Microbiological Techniques
1
2015
30
0.030
 Why?
Risk
1
2018
853
0.030
 Why?
Colony Count, Microbial
1
2015
114
0.030
 Why?
Endotamponade
1
2015
2
0.030
 Why?
Myopia, Degenerative
1
2015
4
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
31
0.030
 Why?
Cerebral Arterial Diseases
1
2015
44
0.030
 Why?
Adolescent
3
2012
20179
0.030
 Why?
Atrophy
1
2015
170
0.030
 Why?
Conjunctiva
1
2014
51
0.030
 Why?
Biometry
1
2014
69
0.030
 Why?
Lens Implantation, Intraocular
1
2015
59
0.030
 Why?
Fetus
1
2018
760
0.030
 Why?
T-Lymphocytes
1
2022
1923
0.030
 Why?
Early Diagnosis
1
2014
234
0.030
 Why?
Safety-net Providers
1
2014
108
0.030
 Why?
Infant, Premature
1
2017
535
0.030
 Why?
Adaptation, Ocular
1
2012
4
0.030
 Why?
Dark Adaptation
1
2012
14
0.030
 Why?
Rats, Mutant Strains
1
2012
24
0.030
 Why?
Sclerostomy
1
2012
4
0.030
 Why?
Child, Preschool
1
2007
10384
0.030
 Why?
Hypoglycemic Agents
1
2021
1212
0.030
 Why?
Cytomegalovirus
1
2013
152
0.020
 Why?
Mothers
1
2018
729
0.020
 Why?
Cell Count
1
2012
313
0.020
 Why?
Drug Implants
1
2012
82
0.020
 Why?
Bruch Membrane
1
2011
6
0.020
 Why?
Gold
1
2012
118
0.020
 Why?
Swine
1
2014
742
0.020
 Why?
Polyglycolic Acid
1
2011
41
0.020
 Why?
Miniaturization
1
2011
23
0.020
 Why?
Administration, Oral
1
2013
754
0.020
 Why?
Drug Stability
1
2011
144
0.020
 Why?
Delayed-Action Preparations
1
2011
170
0.020
 Why?
Chromatography, Gel
1
2010
127
0.020
 Why?
Immunoglobulin Light Chains
1
2010
40
0.020
 Why?
Immunoglobulin Heavy Chains
1
2010
80
0.020
 Why?
Fluorescein
1
2010
25
0.020
 Why?
Comorbidity
1
2015
1543
0.020
 Why?
Molecular Weight
1
2010
331
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2010
323
0.020
 Why?
Aptamers, Nucleotide
1
2010
77
0.020
 Why?
Microfluidic Analytical Techniques
1
2010
73
0.020
 Why?
Particle Size
1
2011
352
0.020
 Why?
Lactic Acid
1
2011
293
0.020
 Why?
Reference Values
1
2010
776
0.020
 Why?
Poverty Areas
1
2008
35
0.020
 Why?
Community Health Centers
1
2008
57
0.020
 Why?
Optic Nerve Diseases
1
2008
34
0.020
 Why?
Fluorescent Dyes
1
2010
311
0.020
 Why?
Kaplan-Meier Estimate
1
2010
853
0.020
 Why?
Models, Biological
1
2015
1691
0.020
 Why?
Kidney Transplantation
1
2013
602
0.020
 Why?
Pilot Projects
1
2012
1563
0.020
 Why?
Imaging, Three-Dimensional
1
2010
533
0.020
 Why?
Polyethylene Glycols
1
2011
596
0.020
 Why?
Pedigree
1
2007
486
0.020
 Why?
Image Processing, Computer-Assisted
1
2010
735
0.020
 Why?
Infusions, Intravenous
1
2006
385
0.020
 Why?
Anti-Bacterial Agents
1
2015
1663
0.020
 Why?
Adrenal Cortex Hormones
1
2008
518
0.010
 Why?
Severity of Illness Index
1
2011
2721
0.010
 Why?
Mass Screening
1
2008
1146
0.010
 Why?
Tomography, X-Ray Computed
1
2010
2523
0.010
 Why?
Risk Assessment
1
2008
3232
0.010
 Why?
Aging
1
2008
1750
0.010
 Why?
Diabetes Mellitus, Type 2
1
2012
2429
0.010
 Why?
Mutation
1
2007
3689
0.010
 Why?
Child
1
2012
20655
0.010
 Why?
Mandava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (373) concept(s)
_
Co-Authors Expand Description
See all (49) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)